Covariance 99mTc-exametazime SPECT patterns in alzheimers disease and dementia with lewy bodies: Utility in differential diagnosis

Journal of Geriatric Psychiatry and Neurology

Volumn 23, Issue 1, 2010, Pages 54-62

  Colloby, Sean J ^a   Taylor, John P ^a   Firbank, Michael J ^a   McKeith, Ian G ^a   Williams, E David ^b   O'Brien, John T ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

Alzheimers disease; Covariance methods; Dementia with Lewy bodies; Differential diagnosis; Perfusion; SPECT

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

AGED; ALZHEIMER DISEASE; ARTICLE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; ROI ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TOPOGRAPHY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BRAIN; CEREBROVASCULAR CIRCULATION; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77349116998     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988709355272     Document Type: Article

References (38)

1. McKeith IG, Galasko D., Kosaka K., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996 47 (5). 1113-1124.
2. Litvan I., Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord. 2003 18 (5). 467-486.
3. McKeith IG, Fairbairn AF, Perry RH, Thompson P. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry. 1994 165 (3). 324-332.
4. Aarsland D., Mosimann UP, McKeith IG Role of cholinesterase inhibitors in Parkinsons disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol. 2004 17 (3). 164-171. (Pubitemid 39128226)
5. Aarsland D., Perry R., Larsen JP, et al. Neuroleptic Sensitivity in Parkinsons Disease and Parkinsonian Dementias. J Clin Psychiatry. 2005 66 (5). 633-637.
6. McKeith I., Fairbairn A., Perry R., Thompson P., Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ. 19 1992 305 (6855). 673-678.
7. Defebvre LJ, Leduc V., Duhamel A., et al. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimers disease and idiopathic Parkinsons disease. J Nucl Med. 1999 40 (6). 956-962.
8. Lobotesis K., Fenwick JD, Phipps A., et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology. 2001 56 (5). 643-649.
9. Pasquier J., Michel BF, Brenot-Rossi I., Hassan-Sebbag N., Sauvan R., Gastaut JL Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies. Eur J Nucl Med Mol Imaging. 2002 29 (10). 1342-1348.
10. Colloby SJ, Fenwick JD, Williams ED, et al. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimers disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging. 2002 29 (5). 615-622.
11. Hanyu H., Shimizu S., Hirao K., et al. Differentiation of dementia with Lewy bodies from Alzheimers disease using Mini-Mental State Examination and brain perfusion SPECT. J Neurol Sci. 2006 250 (1-2). 97-102.
12. Shimizu S., Hanyu H., Kanetaka H., Iwamoto T., Koizumi K., Abe K. Differentiation of dementia with Lewy bodies from Alzheimers disease using brain SPECT. Dement Geriatr Cogn Disord. 2005 20 (1). 25-30.
13. Donnemiller E., Heilmann J., Wenning GK, et al. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med Mol Imaging. 1997 24 (3). 320-325.
14. Kemp PM, Hoffmann SA, Tossici-Bolt L., Fleming JS, Holmes C. Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies. Nucl Med Commun. 007 28 (6). 451-456.
15. Friston KJ, Frith CD, Liddle PF, Frackowiak RS Functional connectivity: the principal-component analysis of large (PET) data sets. J Cereb Blood Flow Metab. 1993 13 (1). 5-14.
16. Gene E. Alexander JRM. Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: A principal component approach to modeling brain function in disease. Hum Brain Mapp. 1994 2 (1-2). 79-94.
17. Horwitz B., McIntosh AR, Haxby JV, Grady CL Network analysis of brain cognitive function using metabolic and blood flow data. Behav Brain Res. 1995 66 (1-2). 187-193.
18. Scarmeas N., Habeck CG, Zarahn E., et al. Covariance PET patterns in early Alzheimers disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. Neuroimage. 2004 23 (1). 35-45.
19. Brickman AM, Habeck C., Zarahn E., Flynn J., Stern Y. Structural MRI covariance patterns associated with normal aging and neuropsychological functioning. Neurobiol Aging. 2007 28 (2). 284-295.
20. Moeller JR, Ishikawa T., Dhawan V., et al. The metabolic topography of normal aging. J Cereb Blood Flow Metab. 1996 16 (3). 385-398.
21. Zuendorf G., Kerrouche N., Herholz K., Baron JC Efficient principal component analysis for multivariate 3D voxel-based mapping of brain functional imaging data sets as applied to FDG-PET and normal aging. Hum Brain Mapp. 2003 18 (1). 13-21.
22. Pagani M., Gardner A., Salmaso D., et al. Principal component and volume of interest analyses in depressed patients imaged by 99mTc-HMPAO SPET: a methodological comparison. Eur J Nucl Med Mol Imaging. 2004 31 (7). 995-1004.
23. Asanuma K., Tang C., Ma Y., et al. Network modulation in the treatment of Parkinsons disease. Brain. 2006 129 (pt 10). 2667-2678.
24. Eckert T., Van Laere K., Tang C., et al. Quantification of Parkinsons disease-related network expression with ECD SPECT. Eur J Nucl Med Mol Imaging. 2007 34 (4). 496-501.
25. Moeller JR, Nakamura T., Mentis MJ, et al. Reproducibility of regional metabolic covariance patterns: comparison of four populations. J Nucl Med. 1999 40 (8). 1264-1269.
26. Asllani I., Habeck C., Scarmeas N., Borogovac A., Brown TR, Stern Y. Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimers disease. J Cereb Blood Flow Metab. 2008 28 (4). 725-736.
27. Devanand DP, Habeck CG, Tabert MH, et al. PET network abnormalities and cognitive decline in patients with mild cognitive impairment. Neuropsychopharmacology. 2006 31 (6). 1327-1334.
28. Johnson KA, Jones K., Holman BL, et al. Preclinical prediction of Alzheimers disease using SPECT. Neurology. 1998 50 (6). 1563-1571.
29. Folstein MF, Folstein SE, McHugh PR Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975 12 (3). 189-198.
30. Roth M., Tym E., Mountjoy CQ, et al. CAMDEX A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia. Br J Psychiatry. 1986 149: 698-709.
31. Fahn S., Elton RL, Marsden CD, Goldstein M. Unified Parkinsons disease rating scale. Recent developments in Parkinsons disease. 1987 2: 153-163.
32. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan EM Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease. Neurology. 1984 34 (7). 939-944.
33. Acton PD, Friston KJ Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies. Eur J Nucl Med Mol Imaging. 1998 25 (7). 663-667.
34. Colloby SJ, Firbank MJ, Pakrasi S., et al. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimers disease and dementia with Lewy bodies. Int Psychogeriatr. 2008: 1-17.
35. Karbe H., Kertesz A., Davis J., Kemp BJ, Prato FS, Nicholson RL Quantification of functional deficit in Alzheimers disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT. Neuroradiology. 1994 36 (1). 1-6.
36. Field AP Discovering Statistics using SPSS for Windows. London: SAGE 2000.
37. Stevens JP Applied Multivariate Statistics for the Social Sciences. 2 nd ed. Hillsdale, NJ: Erlbaum 1992.
38. Firbank MJ, Burn DJ, McKeith IG, OBrien JT Longitudinal study of cerebral blood flow SPECT in Parkinsons disease with dementia, and dementia with Lewy bodies. Int J Geriatr Psychiatry. 2005 20 (8). 776-782.